Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Omalizumab, a recombinant anti-IgE antibody, effectively treats chronic spontaneous urticaria. Evidence is lacking in patients with chronic inducible urticarias (CIndUs), which are frequently H1-antihistamine resistant.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Allergy Clin. Immunol.

Title: The Journal of allergy and clinical immunology

Publisher: Elsevier BV

ISSN (Electronic): 1097-6825

ISSN (Print): 0091-6749

Publication date (Electronic): Feb 2018

Volume: 141

Issue: 2

Affiliations

[1 ] Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.

[2 ] Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

[3 ] Klinik für Hautkrankheiten, Universitätsklinikum Münster, Münster, Germany.

[4 ] Klinik für Dermatologie und Venerologie, Vivantes-Klinikum Berlin-Neukölln, Berlin, Germany.

[5 ] Department of Dermatology and Allergology, University Medical Center Gießen (UKGM), Justus Liebig University Gießen, Giessen, Germany.

[6 ] Department of Dermatology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.

[7 ] Department of Dermatology, Saarland University Medical School, Homburg/Saar, Germany.

[8 ] Hautklinik und Poliklinik der Universitätsmedizin Mainz, Mainz, Germany.

[9 ] the Leipzig Interdisciplinary Allergy Center (LICA), Department of Dermatology, Venereology and Allergology, University Medical Center, Leipzig, Germany.

[10 ] Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, Hannover, Germany.

Article

Publisher Item ID: S0091-6749(17)31163-6

DOI: 10.1016/j.jaci.2017.06.032

PubMed ID: 28751232

SO-VID: 493a867f-128b-43ab-b021-ff09eaac2622

History

Keywords: symptomatic dermographism,therapy,IgE,cholinergic urticaria,physical urticaria

Data availability:

Keywords: symptomatic dermographism, therapy, IgE, cholinergic urticaria, physical urticaria

Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.

Read this article at

Abstract

Related collections

Negative Pressure Wound Therapy

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 177

Cited by 63